Beier J, Watz H, Scholz V, et al. The efficacy of the combination indacaterol/glycopyrronium/mometasone furoate is independent of time of dosing in patients with asthma. Am J Resp Crit Care Med. 2019;199:A1277.
Verschil astma-COPD-overlapsyndroom en ‘adult-onset astma’
jun 2017 | Astma, COPD